igf-1 lr3 hypoglycemia prevention & (Build Blend) - Peptide Therapies IGF1-LR3 (1mg) – Nordsci

Acting as a potent antioxidant, glutathione helps the body eliminate harmful toxins and free radicals, reducing the risk of cell damage

Preclinical Research Dosing Models Animal model studies have explored GHK-Cu at the following ranges: Topical (in vitro/ex vivo): 10100 M concentrations in cell culture media Subcutaneous (rodent models): 15 mg/kg body weight, administered 12x daily Wound healing models: Local application at 110 g/wound site Reconstitution for Research GHK-Cu is typically supplied as a lyophilized powder

& Tang, D

Once reconstituted with bacteriostatic water, peptides require refrigeration at 36-46F and should be used within 4-6 weeks